Monday, May 20, 2019 4:17:29 PM
Total $133K. $55K converted after March 31. So remaining notes around $88K. Lowest pps in last 10 days $0.0036. 65% of that is $0.00234. It will require another close to 37M shares.
I had done a back the envelope math a while ago and posted here that the OS would be around 450M by the time these notes are done.
--------------------------------------------------------
On January 10, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $240,000, convertible into shares of the Company’s common stock, and includes a back-ended note with principal of $120,000 that was funded on July 10, 2018. The back-ended Note, including accrued interest is due July 10, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 15 trading day period ending on the latest complete trading day prior to the conversion date. During the three months ended March 31, 2019, the noteholder converted $66,000 of the principal balance and accrued interest of $4,995 to 44,490,002 shares of common stock. The balance of the note was $100,000 on March 31, 2019.
<u?On September 17, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $33,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due June 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.
Fools argue to win, so stay away from them and still say Thank you.
Smart people argue to seek the truth and say "Thank You" when they find that they are wrong.
Recent NUTX News
- NUTEX HEALTH HOSTS SECOND ANNUAL INTERNAL LEADERSHIP CONFERENCE • PR Newswire (US) • 04/29/2024 09:30:00 AM
- NUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS • PR Newswire (US) • 04/22/2024 09:30:00 AM
- Nutex Health Hospitals Gain Community Recognition and Take Home Seven Patient Satisfaction Awards in Q1 • PR Newswire (US) • 04/16/2024 09:30:00 AM
- NUTEX HEALTH PROVIDES CORPORATE UPDATE • PR Newswire (US) • 04/12/2024 09:30:00 AM
- NUTEX HEALTH OPENS FIRST HOSPITAL OF 2024 IN BELLEVUE, WISCONSIN • PR Newswire (US) • 04/08/2024 09:30:00 AM
- NUTEX HEALTH ANNOUNCES 1-FOR-15 REVERSE STOCK SPLIT • PR Newswire (US) • 04/05/2024 09:30:00 AM
- NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS • PR Newswire (US) • 03/28/2024 10:56:00 PM
- NUTEX HEALTH ANNOUNCES PRELIMINARY 2023 HEADLINE FINANCIALS AND PROVIDES UPDATE ON THE TIMING OF ITS 10-K FILING • PR Newswire (US) • 03/15/2024 09:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:37:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:53:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:59:29 PM
- NUTEX HEALTH ANNOUNCES OVER 100% INCREASE IN MEDICARE ADVANTAGE ENROLLMENT • PR Newswire (US) • 02/05/2024 10:30:00 AM
- /C O R R E C T I O N -- Nutex Health, Inc./ • PR Newswire (US) • 01/31/2024 10:30:00 AM
- NUTEX HEALTH ANNOUNCES YORKVILLE PAYOFF AND STREAMLINED STRATEGIC PLAN • PR Newswire (US) • 01/30/2024 10:30:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/24/2024 09:50:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:45:43 PM
- Nutex Health Announces Pricing of $10.0 Million Registered Direct Offering of Common Stock and Warrants • PR Newswire (US) • 01/23/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 03:59:19 PM
- NUTEX HEALTH TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE • PR Newswire (US) • 12/18/2023 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 08:49:36 PM
- NUTEX HEALTH ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT • PR Newswire (US) • 11/27/2023 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 07:24:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 03:50:01 PM
- NUTEX HEALTH REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS • PR Newswire (US) • 11/09/2023 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:07:11 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM